Novel HIV vaccine trial starts at Oxford  Medical XpressView Full coverage on Google News
The University of Oxford today started vaccinations of a novel HIV vaccine candidate as part of a Phase I clinical trial in the UK.

Novel HIV vaccine trial starts at Oxford

The mosaic vaccine targets a broad range of HIV-1 variants, making it potentially applicable for HIV strains in any geographical region.The mosaic vaccine targets a broad range of HIV-1 variants, making it potentially applicable for HIV strains in any geographical region.

New HIV vaccine trial starts at University of Oxford | Evening Standard